Paspigioni CEO to Speak at COG: CRO Summit UK 2026

We are thrilled to announce that Diana Matiashvili, CEO and Founder of Paspigioni, has been selected as a featured speaker for the upcoming COG: CRO Summit UK, organized by the PBC Group.

As the clinical research landscape undergoes a rapid transformation, Diana will join a prestigious panel of industry experts in London to discuss the future of clinical outsourcing and operational excellence.

Shaping the future of clinical outsourcing

The #CROSummit is a premier gathering for leaders in the Contract Research Organization (CRO) sector. This year’s agenda focuses on the critical intersection of technology and human-centric research—a space where Paspigioni has consistently led with innovation and ethical clinical practice.

Diana will be contributing her insights to key discussions surrounding:

  • The Evolution of Clinical Outsourcing: How to build resilient, transparent partnerships between sponsors and CROs.

  • Technology Integration: Leveraging AI and digital tools to enhance data integrity without losing the "human touch."

  • Patient Engagement: Moving beyond recruitment to create meaningful, long-term engagement strategies in diverse regions.

A Message from our CEO

"The CRO industry is at a pivotal moment. As we look toward 2028 and beyond, our ability to integrate emerging technologies while maintaining deep-rooted clinical ethics is what will define success. I am looking forward to sharing Paspigioni’s journey and learning from my peers in London." - Diana Matiashvili, MD

Join us in London

We invite our partners, clients, and industry colleagues to join us for two days of intensive networking and knowledge-sharing. It is a unique opportunity to get a first-hand look at the strategies shaping the next era of global clinical trials.

Will you be at the CRO Summit? We’d love to meet you there! [Click here to schedule a 1-on-1 meeting] with Diana or our team during the event to discuss how Paspigioni can support your next clinical program.

Previous
Previous

Paspigioni joins the BIO International Convention 2026

Next
Next

Paspigioni Heads to London for BioTrinity’s 20th Anniversary 🧬